Idiopathic Pulmonary Fibrosis: Diagnosis and Epidemiology

Clinics in Chest Medicine

Volumn 33, Issue 1, 2012, Pages 41-50

  Olson, Amy L ^a   Swigris, Jeffrey J ^a  

^a DEPARTMENT OF MEDICINE   (United States)

Author keywords

Diagnosis; Epidemiology; Idiopathic pulmonary fibrosis; Treatment

Indexed keywords

SILICON DIOXIDE;

AGE DISTRIBUTION; AGRICULTURAL WORKER; CIGARETTE SMOKING; CONSENSUS DEVELOPMENT; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DUST; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; EVIDENCE BASED PRACTICE; FIBROSING ALVEOLITIS; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; INCIDENCE; INTERSTITIAL PNEUMONIA; LIVESTOCK; LUNG BIOPSY; LUNG FUNCTION TEST; MORBIDITY; MORTALITY; OCCUPATIONAL EXPOSURE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SAND; SEX DIFFERENCE; SURGICAL LUNG BIOPSY; TRANSBRONCHIAL BIOPSY; WOOD DUST;

ADULT; AGE DISTRIBUTION; AGED; DIAGNOSIS, DIFFERENTIAL; DUST; ENVIRONMENTAL EXPOSURE; FEMALE; GREAT BRITAIN; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INCIDENCE; MALE; MIDDLE AGED; MINNESOTA; MORTALITY; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; SMOKING; UNITED STATES;

EID: 84857384175     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2011.12.001     Document Type: Review

References (52)

1. American Thoracic Society Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000, 161:646-664.
2. American Thoracic Society; European Respiratory Society American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 2001, 165:277-304.
3. Raghu G., Collard H.R., Egan J.J., et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011, 183:788-824.
4. Raghu G., Mageto Y.N., Lockhart D., et al. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest 1999, 116:1168-1174.
5. Hunninghake G.W., Zimmerman M.B., Schwartz D.A., et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001, 164:193-196.
6. Swensen S.J., Aughenbaugh G.L., Meyers J.L. Diffuse lung disease: diagnostic accuracy of CT in patients undergoing surgical biopsy of the lung. Radiology 1997, 205:229-234.
7. Hunninghake G.W., Lynch D.A., Galvin J.R., et al. Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia. Chest 2003, 124:1215-1223.
8. MacDonald S.L., Rubens M.B., Hansell D.M., et al. Nonspecific interstitial pneumonia and usual interstitial pneumonia: comparative appearances at and diagnostic accuracy of thin-section CT. Radiology 2001, 221:600-605.
9. Johkoh T., Muller N.L., Cartier Y., et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999, 211:555-560.
10. Monaghan H., Wells A.U., Colby T.V., et al. Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest 2004, 125:522-526.
11. Flaherty K.R., Travis W.D., Colby T.V., et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Respir Crit Care Med 2001, 164:1722-1727.
12. Flaherty K.R., Thwaite E.L., Kazerooni E.A., et al. Radiological versus histological diagnosis in UIP and NSIP: survival implications. Thorax 2003, 58:143-148.
13. Flaherty K.R., King T.E., Raghu G., et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis?. Am J Respir Crit Care Med 2004, 170:904-910.
14. Lamas D.J., Kawut S.M., Bagiella E., et al. Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med 2011, 184(7):842-847.
15. World Health Organization. Epidemiology. Available at: Accessed June 15, 2011. http://www.who.int/topics/epidemiology/en/.
16. Last J.M. A dictionary of epidemiology 1998, Oxford University Press, New York. 2nd edition.
17. Gordis L. The epidemiologic approach to disease and intervention. Epidemiology 2004, 1-14. Elsevier Saunders, Philadelphia. 3rd edition. L. Gordis (Ed.).
18. Coultas D.B., Hubbard R. Epidemiology of idiopathic pulmonary fibrosis. Idiopathic pulmonary fibrosis 2004, 1-30. Marcel Dekker, New York. J.P. Lynch (Ed.).
19. Leibow A.A., Carrington D.B. The interstitial pneumonias. Frontiers of pulmonary radiology 1969, 102-141. Grune & Stratton, New York. M. Simon, E.J. Potchen, M. LeMay (Eds.).
20. World Health Organization International classification of diseases 1975. 9th revision 1977, WHO, Geneva (Switzerland).
21. Johnston I., Britton J., Kinnear W., et al. Rising mortality from cryptogenic fibrosing alveolitis. BMJ 1990, 301:1017-1021.
22. World Health Organization ICD-10: international classification of diseases and related health problems, 10th revision 2003, WHO, Geneva (Switzerland).
23. Coultas D.B., Hughes M.P. Accuracy or mortality data for interstitial lung disease in New Mexico, USA. Thorax 1996, 51:717-720.
24. Mannino D.M., Etzel R.A., Parrish R.G. Pulmonary fibrosis deaths in the United States, 1979-1991. Am J Respir Crit Care Med 1996, 153:1548-1552.
25. Olson A.L., Swigris J.J., Lezotte D.C., et al. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 2007, 176:277-284.
26. Navaratnam V., Fleming K.M., West J., et al. The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax 2011, 66:462-467.
27. Hubbard R., Johnston I., Coultas D.B., et al. Mortality rates from cryptogenic fibrosing alveolitis in seven countries. Thorax 1996, 51:711-716.
28. Gordis L. Measuring the occurrence of disease: I. Morbidity. Epidemiology 2004, 32-47. Elsevier Saunders, Philadelphia. 3rd edition. L. Gordis (Ed.).
29. Crystal R.G., Bitterman P.B., Rennard S.I., et al. Interstitial lung diseases of unknown causes. Disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984, 310:154-166. 235-44.
30. Scott J., Johnston I., Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. BMJ 1990, 301:1015-1017.
31. U.S. Department of Health and Human Services Vital and health statistics. National hospital discharge survey: annual summary, 1988 1991, DHHS, Hyattsville (MD), No (PHS). p. 91-1101.
32. Coultas D.B., Zumwalt R.E., Black W.C., et al. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 1994, 150:967-972.
33. Raghu G., Weycker D., Edelsberg J., et al. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006, 174:810-816.
34. Gribbin J., Hubbard R.B., Le Jeune I., et al. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006, 61:980-985.
35. Raghu G., Brown K.K., Bradford W.Z., et al. A placebo controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis. N Engl J Med 2004, 350:125-133.
36. Fernández-Pérez E.R., Daniels C.E., Schroeder D.R., et al. Incidence, prevalence, and clinical course of idiopathic pulmonary fibrosis. Chest 2010, 137:129-137.
37. Gordis L. Case-control and cross-sectional studies. Epidemiology 2004, 159-176. Elsevier Saunders, Philadelphia. 3rd edition. L. Gordis (Ed.).
38. Taskar V.S., Coultas D.B. Is idiopathic pulmonary fibrosis an environmental disease?. Proc Am Thorac Soc 2006, 3:293-298.
39. Baumgartner K.B., Samet J.M., Stidley C.A., et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997, 155:242-248.
40. Hubbard R., Lewis S., Richards K., et al. Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis. Lancet 1996, 347:284-289.
41. Iwai K., Mori T., Yamada N., et al. Idiopathic pulmonary fibrosis epidemiologic approaches to occupational exposure. Am J Respir Crit Care Med 1994, 150:670-675.
42. Miyaka Y., Sasaki S., Yokoyama T., et al. Occupational and environmental factors and idiopathic pulmonary fibrosis in Japan. Ann Occup Hyg 2005, 49:259-265.
43. Weissman D.N., Banks D.E. Silicosis. Interstitial lung disease 2003, 387-401. BC Decker, Ontario (Canada). 4th edition. M.I. Schwarz, T.E. King (Eds.).
44. Banks D.E. Coal workers' pneumoconiosis. Interstitial lung disease 2003, 402-417. BC Decker, Ontario (Canada). 4th edition. M.I. Schwarz, T.E. King (Eds.).
45. Steele M., Peterson M.W., Schwarz D.A. Asbestosis and asbestos-induced pleural fibrosis. Interstitial lung disease 2003, 418-434. BC Decker, Ontario (Canada). 4th edition. M.I. Schwarz, T.E. King (Eds.).
46. Baumgarter K.B., Samet J.M., Coutas D.B., et al. Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study. Am J Epidemiol 2000, 152:307-315.
47. Hashimoto H., Tajima H., Mizoguchi I., et al. Nihon Kyobu Shikkan Gakkai Zasshi 1992, 30:2061-2068. [in Japanese].
48. Kitamura H., Ichinose S., Hosoya T., et al. Inhalation of inorganic particles as a risk factor for idiopathic pulmonary fibrosis-elemental microanalysis of pulmonary lymph nodes obtained at autopsy cases. Pathol Res Pract 2007, 203:575-585.
49. Gustafson T., Dahlman-Ho{doubleacute}glund A., Nilsson K., et al. Occupational exposure and severe pulmonary fibrosis. Respir Med 2007, 110:2207-2212.
50. Hubbard R., Cooper M., Antaoniak M., et al. Risk of cryptogenic fibrosing alveolitis in metal workers. Lancet 2000, 355:466-467.
51. Pinheiro G.A., Antao V.C., Wood J.M., et al. Occupational risks for idiopathic pulmonary fibrosis mortality in the United States. Int J Occup Environ Health 2008, 14:117-123.
52. Mullen J., Hodgson M.J., DeGraff C.A., et al. Case-control study of idiopathic pulmonary fibrosis and environmental exposures. J Occup Environ Med 1998, 40:363-367.